Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging

Sickle Cell Disease Clinical Trial

Official title:

Identifying Patient-centered Barriers and Preferred Strategies to Support Self-efficacy for Medication Adherence With Two-way Text Messaging

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02785848
• Other study ID #: 160750
• Status: Active, not recruiting
• Start date: May 2016
• Est. completion date: July 2024

Study information

• Verified date: September 2023
• Source: Vanderbilt University Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators will explore barriers to improving self-efficacy, or the ability to feel in control of their disease, and medication adherence with text messaging through surveys and interviews with adolescents and adults with SCD cared for at the Vanderbilt Meharry Center of Excellence (VMCE) in Sickle Cell Disease (SCD). The investigators will identify preferences to improve and sustain adherence to daily medication through selection of investigator-proposed or patient-generated text messaging strategies. Finally, the investigators will fill in the literature gaps by describing barriers to self-efficacy and medication adherence among adults with SCD as well as adolescents with SCD who are transitioning to adult care.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 70
• Est. completion date: July 2024
• Est. primary completion date: May 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years to 70 Years

Eligibility

Inclusion Criteria:

1. Receiving care at the VUMC/Matthew Walker clinic

2. Diagnosed with SCD, asthma, or both

3. Currently taking daily medications for SCD, such as hydroxyurea, asthma, or both

4. Having access to a mobile telephone and/or computer

5. Age 12-70 years

Exclusion Criteria:

1. Unable to perform interviews or surveys

Related Conditions & MeSH terms

• Anemia, Sickle Cell
• Sickle Cell Disease

Intervention

Other:
• Interviews and Surveys
The investigators will perform semi-structured interviews and surveys on this cohort

Locations

Country	Name	City	State
United States	Vanderbilt University	Nashville	Tennessee

Sponsors (1)

Lead Sponsor	Collaborator
Vanderbilt University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients with barriers to medication adherence	High cost, forgetting, side effects, access to medications	1 year
Secondary	Number of patients that prefer a tailored text messaging technological solution		1 year